Pneumonia News

Influenza reached epidemic levels in Chile months earlier than a typical influenza season, just like in several other Southern Hemisphere countries, researchers reported.

Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open.

WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.

NASHVILLE, Tenn. — Patients who were hospitalized with bacterial pneumonia with co-existing iron deficiency anemia did not have worse outcomes, including mortality, septic shock, acute respiratory failure and cardiac arrest.

Patients with COVID-19 in the ICU safely and effectively received direct oral challenges for low-risk and unverified penicillin allergies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The Healio Editors compiled the most-read news in pulmonology posted in September.

In a new study, most patients with community-acquired pneumonia did not receive testing for influenza, even during influenza season, researchers reported in Chest.

Treatment with vilobelimab reduced mortality at 28 to 60 days in patients with severe COVID-19 pneumonia without increasing infections, according to data presented at the European Respiratory Society International Congress.

Patients with normal oxygenation levels who were treated for possible pneumonia experienced similar outcomes with an “ultrashort” course of antibiotics compared with a longer course, researchers reported recently.

Undergoing preventive dental treatment within 12 months or periodontal treatment within 6 months of hospitalization was associated with a reduced risk for nonventilator hospital-acquired pneumonia, researchers found.